Cargando…

miR‐30b protects nigrostriatal dopaminergic neurons from MPP(+)‐induced neurotoxicity via SNCA

OBJECTIVE: To explore the function of miR‐30b in pathogenesis of Parkinson's disease (PD) and its underlying molecular mechanism. MATERIALS AND METHODS: We used 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPP(+)) as a tool for constructing the PD cell model, using miR‐30b mimics or inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Yu‐fei, Zhu, Zhuo‐ying, Qian, Shu‐xia, Xu, Cong‐ying, Wang, Yan‐ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177592/ https://www.ncbi.nlm.nih.gov/pubmed/32154657 http://dx.doi.org/10.1002/brb3.1567

Ejemplares similares

Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP(+) and MPTP Induced Neurotoxicity: Roles of Nrf2-ARE Signaling Pathway
por: Guo, Xingfang, et al.
Publicado: (2019)

Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons
por: Aguirre, Pabla, et al.
Publicado: (2015)

7,8-Dihydroxyflavone Protects Nigrostriatal Dopaminergic Neurons from Rotenone-Induced Neurotoxicity in Rodents
por: Nie, Shuke, et al.
Publicado: (2019)

Wld(S )but not Nmnat1 protects dopaminergic neurites from MPP(+ )neurotoxicity
por: Antenor-Dorsey, Jo Ann V, et al.
Publicado: (2012)

A Current Review of Cypermethrin-Induced Neurotoxicity and Nigrostriatal Dopaminergic Neurodegeneration
por: Singh, Anand Kumar, et al.
Publicado: (2012)

Bacopa Protects against Neurotoxicity Induced by MPP(+) and Methamphetamine
por: Ferrucci, Michela, et al.
Publicado: (2022)

Quercetin Protects against MPP(+)/MPTP-Induced Dopaminergic Neuron Death in Parkinson's Disease by Inhibiting Ferroptosis
por: Lin, Zhi-Hao, et al.
Publicado: (2022)

Nesfatin-1 protects dopaminergic neurons against MPP(+)/MPTP-induced neurotoxicity through the C-Raf–ERK1/2-dependent anti-apoptotic pathway
por: Shen, Xiao-Li, et al.
Publicado: (2017)

Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity
por: Segura-Aguilar, Juan, et al.
Publicado: (2022)

Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice
por: Wang, Qingshan, et al.
Publicado: (2012)

Atrazine Causes Autophagy- and Apoptosis-Related Neurodegenerative Effects in Dopaminergic Neurons in the Rat Nigrostriatal Dopaminergic System
por: Song, Xiao-Yao, et al.
Publicado: (2015)

Paeonolum protects against MPP(+)-induced neurotoxicity in zebrafish and PC12 cells
por: Lu, Xi-Lin, et al.
Publicado: (2015)

Engineering synucleinopathy‐resistant human dopaminergic neurons by CRISPR‐mediated deletion of the SNCA gene
por: Chen, Yixi, et al.
Publicado: (2018)

Naringin: A Protector of the Nigrostriatal Dopaminergic Projection
por: Jung, Un Ju, et al.
Publicado: (2014)

TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
por: Zheng, Cong, et al.
Publicado: (2018)

Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit
por: Pham, Anh H., et al.
Publicado: (2012)

No apparent transmission of transgenic α–synuclein into nigrostriatal dopaminergic neurons in multiple mouse models
por: Sastry, Namratha, et al.
Publicado: (2015)

Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
por: Lee, Yang Hyun, et al.
Publicado: (2019)

Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
por: Morales, Ingrid, et al.
Publicado: (2021)

Involvement of the ERK pathway in the protective effects of glycyrrhizic acid against the MPP(+)-induced apoptosis of dopaminergic neuronal cells
por: TENG, LESHENG, et al.
Publicado: (2014)

Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP(+) and Rotenone Toxicity
por: Bayer Andersen, Kirsten, et al.
Publicado: (2016)

Nigrostriatal dopaminergic depletion increases static orofacial allodynia
por: Dieb, Wisam, et al.
Publicado: (2016)

Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission
por: Qin, Qi, et al.
Publicado: (2016)

Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease
por: Wi, Rayul, et al.
Publicado: (2020)

miR-7 and miR-153 protect neurons against MPP(+)-induced cell death via upregulation of mTOR pathway
por: Fragkouli, Apostolia, et al.
Publicado: (2014)

Neuroprotective Effects of 7, 8-dihydroxyflavone on Midbrain Dopaminergic Neurons in MPP(+)-treated Monkeys
por: He, Jingjing, et al.
Publicado: (2016)

Effects of Apamin on MPP(+)-Induced Calcium Overload and Neurotoxicity by Targeting CaMKII/ERK/p65/STAT3 Signaling Pathways in Dopaminergic Neuronal Cells
por: Park, Jihyun, et al.
Publicado: (2022)

Inhibition of Microglia-Derived Oxidative Stress by Ciliary Neurotrophic Factor Protects Dopamine Neurons In Vivo from MPP(+) Neurotoxicity
por: Baek, Jeong Yeob, et al.
Publicado: (2018)

Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Protective effect of alpha-synuclein knockdown on methamphetamine-induced neurotoxicity in dopaminergic neurons
por: Tai, Yunchun, et al.
Publicado: (2014)

Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons
por: Claros, Silvia, et al.
Publicado: (2021)

MiR-212 Attenuates MPP(+)-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells
por: Song, Yanfeng, et al.
Publicado: (2018)

Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopaminergic deficiency.
por: Jeon, B. S.
Publicado: (1997)

Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia
por: Dieb, Wisam, et al.
Publicado: (2014)

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
por: Lee, Seung Ha, et al.
Publicado: (2017)

Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
por: Herrera, Macarena L., et al.
Publicado: (2020)

Glucose Levels in Culture Medium Determine Cell Death Mode in MPP(+)-treated Dopaminergic Neuronal Cells
por: Yoon, So-Young, et al.
Publicado: (2015)

Mitochondrial Dysfunction in Dopaminergic Neurons Derived from Patients with LRRK2- and SNCA-Associated Genetic Forms of Parkinson’s Disease
por: Vetchinova, Anna S., et al.
Publicado: (2023)

Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate
por: Harrison, Ian F., et al.
Publicado: (2016)

Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson’s disease
por: Cai, Huaibin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s97ehmudko2k6rkiklkthed4e1